Brain invasion in otherwise benign meningiomas does not predict tumor recurrence

Acta Neuropathol. 2016 Sep;132(3):479-81. doi: 10.1007/s00401-016-1598-1. Epub 2016 Jul 27.

Peter Baumgarten¹, Florian Gessler¹, Jens Schittenhelm^{2

3}, Marco Skardelly^{3

4}, Dominique S Tews⁵, Christian Senft¹, Maika Dunst⁵, Lioba Imoehl¹, Karl H Plate^{5

6

7}, Marlies Wagner⁸, Joachim P Steinbach^{6

7

9}, Volker Seifert¹, Michel Mittelbronn^{5

6

7}, Patrick N Harter^{10

11

12}

¹ Department of Neurosurgery, Goethe University Frankfurt, Frankfurt am Main, Germany.
² Department of Neuropathology, Eberhard-Karls University Tübingen, Tübingen, Germany.
³ Center for CNS tumors, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany.
⁴ Department of Neurosurgery, Eberhard-Karls University Tübingen, Tübingen, Germany.
⁵ Edinger Institute, Institute of Neurology, Goethe University Frankfurt, 60528, Frankfurt am Main, Germany.
⁶ German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Frankfurt, Germany.
⁷ German Cancer Research Center (DKFZ), Heidelberg, Germany.
⁸ Department of Neuroradiology, Goethe University Frankfurt, Frankfurt am Main, Germany.
⁹ Dr. Senckenberg Institute of Neurooncology, Goethe University Frankfurt, Frankfurt am Main, Germany.
¹⁰ Edinger Institute, Institute of Neurology, Goethe University Frankfurt, 60528, Frankfurt am Main, Germany. patrick.harter@kgu.de.
¹¹ German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Frankfurt, Germany. patrick.harter@kgu.de.
¹² German Cancer Research Center (DKFZ), Heidelberg, Germany. patrick.harter@kgu.de.

No abstract available

Publication types